Symbol:
Lxn
Name:
latexin
RGD ID:
68361
Description:
Predicted to enable metalloendopeptidase inhibitor activity. Predicted to be involved in inflammatory response. Predicted to act upstream of or within detection of temperature stimulus involved in sensory perception of pain. Predicted to be located in cytoplasm. Predicted to be active in extracellular space. Orthologous to human LXN (latexin); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 3-chloropropane-1,2-diol; 4,4'-diaminodiphenylmethane.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
ECI; endogenous carboxypeptidase inhibitor; MGC93322; TCI; tissue carboxypeptidase inhibitor
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
LXN (latexin) HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Lxn (latexin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Lxn (latexin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
LXN (latexin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
LXN (latexin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Lxn (latexin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
LXN (latexin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
LXN (latexin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Lxn (latexin) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Mus musculus (house mouse):
Lxn (latexin)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
LXN (latexin)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
lxn (latexin)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 2 154,037,604 - 154,043,473 (-) NCBI GRCr8 mRatBN7.2 2 151,727,556 - 151,733,426 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 2 151,727,102 - 151,733,460 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 2 158,844,126 - 158,849,894 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 2 156,894,624 - 156,900,393 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 2 151,527,375 - 151,533,143 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 2 164,628,565 - 164,634,434 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 164,628,566 - 164,634,434 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 183,977,968 - 183,983,837 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 157,310,036 - 157,315,905 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 2 157,259,999 - 157,265,868 (-) NCBI Celera 2 146,097,077 - 146,102,946 (-) NCBI Celera Cytogenetic Map 2 q32 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Lxn Rat (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:737325 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LXN mRNA CTD PMID:22079256 Lxn Rat 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO RGD:737325 6480464 o,p'-DDT results in decreased expression of LXN mRNA CTD PMID:18204070 Lxn Rat 1,1-dichloroethene increases expression ISO RGD:68514 6480464 vinylidene chloride results in increased expression of LXN mRNA CTD PMID:26682919 Lxn Rat 1,2-dichloroethane decreases expression ISO RGD:68514 6480464 ethylene dichloride results in decreased expression of LXN mRNA CTD PMID:28960355 Lxn Rat 1,2-dimethylhydrazine increases expression ISO RGD:68514 6480464 1,2-Dimethylhydrazine results in increased expression of LXN mRNA CTD PMID:22206623 Lxn Rat 17alpha-ethynylestradiol multiple interactions ISO RGD:68514 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LXN mRNA CTD PMID:17942748 Lxn Rat 17beta-estradiol multiple interactions ISO RGD:737325 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LXN mRNA; [Estradiol co-treated with TGFB1 more ... CTD PMID:17404688|PMID:19619570|PMID:24758408|PMID:30165855 Lxn Rat 17beta-estradiol decreases expression ISO RGD:737325 6480464 Estradiol results in decreased expression of LXN mRNA CTD PMID:19619570|PMID:21185374|PMID:23019147|PMID:24758408 Lxn Rat 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RGD:737325 6480464 2,5,2',5'-tetrachlorobiphenyl results in decreased expression of LXN mRNA CTD PMID:36804509 Lxn Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737325 6480464 Tetrachlorodibenzodioxin results in decreased expression of LXN mRNA CTD PMID:19619570 Lxn Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LXN mRNA CTD PMID:33387578|PMID:34747641 Lxn Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LXN mRNA CTD PMID:22298810 Lxn Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:68514 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LXN mRNA CTD PMID:17942748 Lxn Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737325 6480464 Tetrachlorodibenzodioxin results in increased expression of LXN mRNA CTD PMID:17517823 Lxn Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737325 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LXN mRNA CTD PMID:19619570 Lxn Rat 2-butoxyethanol decreases expression ISO RGD:68514 6480464 n-butoxyethanol results in decreased expression of LXN mRNA CTD PMID:19812364 Lxn Rat 3,4-methylenedioxymethamphetamine increases methylation ISO RGD:68514 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of LXN promoter CTD PMID:26251327 Lxn Rat 3,4-methylenedioxymethamphetamine increases expression ISO RGD:68514 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of LXN mRNA CTD PMID:26251327 Lxn Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of LXN protein CTD PMID:34915118 Lxn Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737325 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of more ... CTD PMID:16997883 Lxn Rat 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4,4'-diaminodiphenylmethane results in increased expression of LXN mRNA CTD PMID:30723492 Lxn Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Lxn Rat 4-hydroxyphenyl retinamide increases expression ISO RGD:68514 6480464 Fenretinide results in increased expression of LXN mRNA CTD PMID:28973697 Lxn Rat 5-aza-2'-deoxycytidine affects expression ISO RGD:737325 6480464 Decitabine affects the expression of LXN mRNA CTD PMID:17145863 Lxn Rat 5-fluorouracil affects response to substance ISO RGD:737325 6480464 LXN protein affects the susceptibility to Fluorouracil CTD PMID:16217747 Lxn Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of LXN mRNA CTD PMID:30047161 Lxn Rat 8-Br-cAMP multiple interactions ISO RGD:737325 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of more ... CTD PMID:16997883 Lxn Rat acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of LXN mRNA CTD PMID:28959563 Lxn Rat aflatoxin B1 increases expression ISO RGD:68514 6480464 Aflatoxin B1 results in increased expression of LXN mRNA CTD PMID:19770486 Lxn Rat alachlor increases expression EXP 6480464 alachlor results in increased expression of LXN mRNA CTD PMID:12419858 Lxn Rat all-trans-retinoic acid increases expression ISO RGD:737325 6480464 Tretinoin results in increased expression of LXN mRNA CTD PMID:23830798 Lxn Rat amitrole increases expression EXP 6480464 Amitrole results in increased expression of LXN mRNA CTD PMID:30047161 Lxn Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LXN mRNA CTD PMID:16483693 Lxn Rat arsenite(3-) increases expression ISO RGD:68514 6480464 arsenite results in increased expression of LXN protein CTD PMID:37955338 Lxn Rat azathioprine increases expression ISO RGD:737325 6480464 Azathioprine results in increased expression of LXN mRNA CTD PMID:19192274 Lxn Rat benzo[a]pyrene affects expression ISO RGD:737325 6480464 Benzo(a)pyrene affects the expression of LXN mRNA CTD PMID:21714911 Lxn Rat benzo[a]pyrene affects methylation ISO RGD:737325 6480464 Benzo(a)pyrene affects the methylation of LXN promoter CTD PMID:27901495 Lxn Rat benzo[a]pyrene increases expression ISO RGD:68514 6480464 Benzo(a)pyrene results in increased expression of LXN mRNA CTD PMID:19770486|PMID:22228805|PMID:22610609 Lxn Rat benzo[a]pyrene diol epoxide I affects expression ISO RGD:737325 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of LXN mRNA CTD PMID:20382639 Lxn Rat benzo[b]fluoranthene increases expression ISO RGD:68514 6480464 benzo(b)fluoranthene results in increased expression of LXN mRNA CTD PMID:26377693 Lxn Rat beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LXN mRNA CTD PMID:18164116 Lxn Rat biochanin A increases expression ISO RGD:737325 6480464 biochanin A results in increased expression of LXN mRNA CTD PMID:12111696 Lxn Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LXN mRNA CTD PMID:25181051 Lxn Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Lxn Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LXN mRNA CTD PMID:30816183|PMID:32528016 Lxn Rat bisphenol A increases expression ISO RGD:737325 6480464 bisphenol A results in increased expression of LXN mRNA CTD PMID:27685785 Lxn Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Lxn Rat Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of LXN protein CTD PMID:28903499 Lxn Rat calcitriol multiple interactions ISO RGD:737325 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of LXN mRNA CTD PMID:21592394 Lxn Rat calcitriol increases expression ISO RGD:737325 6480464 Calcitriol results in increased expression of LXN mRNA CTD PMID:21592394 Lxn Rat choline multiple interactions ISO RGD:68514 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... CTD PMID:20938992 Lxn Rat cobalt dichloride decreases expression ISO RGD:737325 6480464 cobaltous chloride results in decreased expression of LXN mRNA CTD PMID:19320972 Lxn Rat copper(II) chloride decreases expression ISO RGD:737325 6480464 cupric chloride results in decreased expression of LXN mRNA CTD PMID:38568856 Lxn Rat crocidolite asbestos decreases expression ISO RGD:737325 6480464 Asbestos, Crocidolite results in decreased expression of LXN mRNA CTD PMID:18687144 Lxn Rat cyclosporin A decreases expression ISO RGD:68514 6480464 Cyclosporine results in decreased expression of LXN mRNA CTD PMID:19770486 Lxn Rat dexamethasone multiple interactions ISO RGD:737325 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of more ... CTD PMID:16997883 Lxn Rat dexamethasone decreases expression ISO RGD:737325 6480464 Dexamethasone results in decreased expression of LXN mRNA CTD PMID:25047013 Lxn Rat dibenz[a,h]anthracene increases expression ISO RGD:68514 6480464 1,2,5,6-dibenzanthracene results in increased expression of LXN mRNA CTD PMID:26377693 Lxn Rat diclofenac increases expression ISO RGD:737325 6480464 Diclofenac results in increased expression of LXN mRNA CTD PMID:19192274 Lxn Rat dioxygen multiple interactions ISO RGD:68514 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LXN mRNA CTD PMID:30529165 Lxn Rat diuron increases expression EXP 6480464 Diuron results in increased expression of LXN mRNA CTD PMID:21551480 Lxn Rat doxorubicin decreases expression ISO RGD:737325 6480464 Doxorubicin results in decreased expression of LXN mRNA CTD PMID:29803840 Lxn Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of LXN mRNA CTD PMID:29391264 Lxn Rat etoposide increases response to substance ISO RGD:68514 6480464 LXN protein results in increased susceptibility to Etoposide CTD PMID:25341047 Lxn Rat flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of LXN mRNA CTD PMID:18035473 Lxn Rat folic acid multiple interactions ISO RGD:68514 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... CTD PMID:20938992 Lxn Rat formaldehyde increases expression ISO RGD:737325 6480464 Formaldehyde results in increased expression of LXN mRNA CTD PMID:23649840 Lxn Rat furan increases expression EXP 6480464 furan results in increased expression of LXN mRNA CTD PMID:27387713 Lxn Rat genistein decreases expression ISO RGD:737325 6480464 Genistein results in decreased expression of LXN mRNA CTD PMID:23019147 Lxn Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of LXN mRNA CTD PMID:33387578 Lxn Rat glycidyl methacrylate decreases expression ISO RGD:737325 6480464 glycidyl methacrylate results in decreased expression of LXN protein CTD PMID:36641056 Lxn Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of LXN mRNA CTD PMID:21396975 Lxn Rat L-ascorbic acid increases expression ISO RGD:68514 6480464 Ascorbic Acid results in increased expression of LXN mRNA; Ascorbic Acid results in increased expression more ... CTD PMID:22139585 Lxn Rat L-methionine multiple interactions ISO RGD:68514 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... CTD PMID:20938992 Lxn Rat lucanthone increases expression ISO RGD:737325 6480464 Lucanthone results in increased expression of LXN mRNA CTD PMID:21148553 Lxn Rat methimazole increases expression EXP 6480464 Methimazole results in increased expression of LXN mRNA CTD PMID:30047161 Lxn Rat methotrexate increases expression ISO RGD:737325 6480464 Methotrexate results in increased expression of LXN mRNA CTD PMID:19192274 Lxn Rat methylmercury chloride decreases expression ISO RGD:737325 6480464 methylmercuric chloride results in decreased expression of LXN mRNA CTD PMID:28001369 Lxn Rat mifepristone increases expression ISO RGD:737325 6480464 Mifepristone results in increased expression of LXN mRNA CTD PMID:17584828 Lxn Rat Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of LXN mRNA CTD PMID:21515302 Lxn Rat N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:68514 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of LXN mRNA CTD PMID:25566086 Lxn Rat N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:68514 6480464 MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of LXN mRNA] CTD PMID:25566086 Lxn Rat N-ethyl-N-nitrosourea increases expression EXP 6480464 Ethylnitrosourea results in increased expression of LXN mRNA CTD PMID:15954086 Lxn Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LXN mRNA CTD PMID:18164116 Lxn Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LXN mRNA CTD PMID:25729387 Lxn Rat oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of LXN mRNA CTD PMID:25729387 Lxn Rat paracetamol decreases expression ISO RGD:737325 6480464 Acetaminophen results in decreased expression of LXN mRNA CTD PMID:21420995 Lxn Rat phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of LXN mRNA CTD PMID:19162173 Lxn Rat piroxicam increases expression ISO RGD:737325 6480464 Piroxicam results in increased expression of LXN mRNA CTD PMID:19192274 Lxn Rat potassium chromate decreases expression ISO RGD:737325 6480464 potassium chromate(VI) results in decreased expression of LXN mRNA CTD PMID:22079256 Lxn Rat potassium chromate multiple interactions ISO RGD:737325 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LXN mRNA CTD PMID:22079256 Lxn Rat progesterone multiple interactions ISO RGD:737325 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of LXN mRNA CTD PMID:17404688 Lxn Rat resveratrol increases expression ISO RGD:68514 6480464 resveratrol results in increased expression of LXN protein CTD PMID:25505154 Lxn Rat sodium arsenite decreases expression ISO RGD:737325 6480464 sodium arsenite results in decreased expression of LXN mRNA CTD PMID:34032870|PMID:38568856 Lxn Rat sodium arsenite decreases expression ISO RGD:68514 6480464 sodium arsenite results in decreased expression of LXN mRNA CTD PMID:37682722 Lxn Rat sodium aurothiomalate increases expression ISO RGD:737325 6480464 Gold Sodium Thiomalate results in increased expression of LXN mRNA CTD PMID:19192274 Lxn Rat sodium fluoride decreases expression ISO RGD:68514 6480464 Sodium Fluoride results in decreased expression of LXN protein CTD PMID:28918527 Lxn Rat sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of LXN mRNA CTD PMID:30047161 Lxn Rat sulforaphane decreases expression ISO RGD:737325 6480464 sulforaphane results in decreased expression of LXN mRNA CTD PMID:31838189 Lxn Rat sunitinib decreases expression ISO RGD:737325 6480464 Sunitinib results in decreased expression of LXN mRNA CTD PMID:31533062 Lxn Rat temozolomide decreases expression ISO RGD:737325 6480464 Temozolomide results in decreased expression of LXN mRNA CTD PMID:31758290 Lxn Rat Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of LXN mRNA CTD PMID:21515302 Lxn Rat testosterone multiple interactions ISO RGD:737325 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of LXN mRNA CTD PMID:21592394 Lxn Rat testosterone increases expression ISO RGD:737325 6480464 Testosterone results in increased expression of LXN mRNA CTD PMID:21592394 Lxn Rat tetrachloromethane affects expression ISO RGD:68514 6480464 Carbon Tetrachloride affects the expression of LXN mRNA CTD PMID:17484886 Lxn Rat thiram decreases expression ISO RGD:737325 6480464 Thiram results in decreased expression of LXN mRNA CTD PMID:38568856 Lxn Rat titanium dioxide decreases methylation ISO RGD:68514 6480464 titanium dioxide results in decreased methylation of LXN gene CTD PMID:35295148 Lxn Rat topotecan increases expression EXP 6480464 Topotecan results in increased expression of LXN mRNA CTD PMID:25729387 Lxn Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LXN mRNA CTD PMID:25729387 Lxn Rat triadimefon increases expression EXP 6480464 triadimefon results in increased expression of LXN mRNA CTD PMID:30047161 Lxn Rat trimellitic anhydride increases expression ISO RGD:68514 6480464 trimellitic anhydride results in increased expression of LXN mRNA CTD PMID:19042947 Lxn Rat triphenyl phosphate affects expression ISO RGD:737325 6480464 triphenyl phosphate affects the expression of LXN mRNA CTD PMID:37042841 Lxn Rat triptonide decreases expression ISO RGD:68514 6480464 triptonide results in decreased expression of LXN mRNA CTD PMID:33045310 Lxn Rat troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of LXN mRNA CTD PMID:21515302 Lxn Rat valproic acid increases methylation ISO RGD:737325 6480464 Valproic Acid results in increased methylation of LXN gene CTD PMID:29154799 Lxn Rat valproic acid decreases expression ISO RGD:737325 6480464 Valproic Acid results in decreased expression of LXN mRNA CTD PMID:23179753|PMID:28001369 Lxn Rat valproic acid affects expression ISO RGD:737325 6480464 Valproic Acid affects the expression of LXN mRNA CTD PMID:25979313 Lxn Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of LXN mRNA CTD PMID:23034163
(-)-epigallocatechin 3-gallate (ISO) 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane (ISO) 1,1-dichloroethene (ISO) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (ISO) 2,2',5,5'-tetrachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-butoxyethanol (ISO) 3,4-methylenedioxymethamphetamine (ISO) 3-chloropropane-1,2-diol (EXP) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-diaminodiphenylmethane (EXP) 4,4'-sulfonyldiphenol (EXP) 4-hydroxyphenyl retinamide (ISO) 5-aza-2'-deoxycytidine (ISO) 5-fluorouracil (ISO) 6-propyl-2-thiouracil (EXP) 8-Br-cAMP (ISO) acrylamide (EXP) aflatoxin B1 (ISO) alachlor (EXP) all-trans-retinoic acid (ISO) amitrole (EXP) ammonium chloride (EXP) arsenite(3-) (ISO) azathioprine (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) benzo[b]fluoranthene (ISO) beta-naphthoflavone (EXP) biochanin A (ISO) bisphenol A (EXP,ISO) bisphenol F (EXP) Brodifacoum (EXP) calcitriol (ISO) choline (ISO) cobalt dichloride (ISO) copper(II) chloride (ISO) crocidolite asbestos (ISO) cyclosporin A (ISO) dexamethasone (ISO) dibenz[a,h]anthracene (ISO) diclofenac (ISO) dioxygen (ISO) diuron (EXP) doxorubicin (ISO) endosulfan (EXP) etoposide (ISO) flavonoids (EXP) folic acid (ISO) formaldehyde (ISO) furan (EXP) genistein (ISO) gentamycin (EXP) glycidyl methacrylate (ISO) indole-3-methanol (EXP) L-ascorbic acid (ISO) L-methionine (ISO) lucanthone (ISO) methimazole (EXP) methotrexate (ISO) methylmercury chloride (ISO) mifepristone (ISO) Muraglitazar (EXP) N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal (ISO) N-ethyl-N-nitrosourea (EXP) N-nitrosodiethylamine (EXP) oxaliplatin (EXP) paracetamol (ISO) phenobarbital (EXP) piroxicam (ISO) potassium chromate (ISO) progesterone (ISO) resveratrol (ISO) sodium arsenite (ISO) sodium aurothiomalate (ISO) sodium fluoride (ISO) sulfadimethoxine (EXP) sulforaphane (ISO) sunitinib (ISO) temozolomide (ISO) Tesaglitazar (EXP) testosterone (ISO) tetrachloromethane (ISO) thiram (ISO) titanium dioxide (ISO) topotecan (EXP) triadimefon (EXP) trimellitic anhydride (ISO) triphenyl phosphate (ISO) triptonide (ISO) troglitazone (EXP) valproic acid (ISO) vinclozolin (EXP)
1.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
2.
Intracortical regionality represented by specific transcription for a novel protein, latexin.
Hatanaka Y, etal., Eur J Neurosci 1994 Jun 1;6(6):973-82.
3.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
4.
Genomic organization and regulatory elements of the rat latexin gene, which is expressed in a cell type-specific manner in both central and peripheral nervous systems.
Miyasaka N, etal., Brain Res Mol Brain Res 1999 May 21;69(1):62-72.
5.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
6.
Purification, cDNA cloning, functional expression, and characterization of a 26-kDa endogenous mammalian carboxypeptidase inhibitor.
Normant E, etal., Proc Natl Acad Sci U S A 1995 Dec 19;92(26):12225-9.
7.
GOA pipeline
RGD automated data pipeline
8.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
9.
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.
Strausberg RL, etal., Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.
Lxn Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 2 154,037,604 - 154,043,473 (-) NCBI GRCr8 mRatBN7.2 2 151,727,556 - 151,733,426 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 2 151,727,102 - 151,733,460 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 2 158,844,126 - 158,849,894 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 2 156,894,624 - 156,900,393 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 2 151,527,375 - 151,533,143 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 2 164,628,565 - 164,634,434 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 164,628,566 - 164,634,434 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 183,977,968 - 183,983,837 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 157,310,036 - 157,315,905 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 2 157,259,999 - 157,265,868 (-) NCBI Celera 2 146,097,077 - 146,102,946 (-) NCBI Celera Cytogenetic Map 2 q32 NCBI
LXN Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 3 158,666,414 - 158,672,648 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 3 158,645,822 - 158,672,648 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 3 158,384,203 - 158,390,437 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 3 159,866,900 - 159,873,176 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 3 159,866,907 - 159,873,184 NCBI Celera 3 156,806,788 - 156,813,067 (-) NCBI Celera Cytogenetic Map 3 q25.32 NCBI HuRef 3 155,780,049 - 155,786,328 (-) NCBI HuRef CHM1_1 3 158,347,170 - 158,353,449 (-) NCBI CHM1_1 T2T-CHM13v2.0 3 161,440,336 - 161,446,570 (-) NCBI T2T-CHM13v2.0
Lxn Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 3 67,365,332 - 67,371,240 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 3 67,365,331 - 67,371,259 (-) Ensembl GRCm39 Ensembl GRCm38 3 67,457,999 - 67,463,907 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 3 67,457,998 - 67,463,926 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 3 67,261,921 - 67,267,829 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 3 67,545,928 - 67,551,836 (-) NCBI MGSCv36 mm8 Celera 3 67,584,098 - 67,590,006 (-) NCBI Celera Cytogenetic Map 3 E1 NCBI cM Map 3 30.98 NCBI
Lxn Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955448 9,414,721 - 9,421,575 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955448 9,414,721 - 9,421,575 (-) NCBI ChiLan1.0 ChiLan1.0
LXN Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 2 156,608,664 - 156,617,760 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 3 156,613,379 - 156,619,970 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 3 155,692,283 - 155,698,605 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 3 163,743,319 - 163,749,614 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 3 163,743,319 - 163,749,614 (-) Ensembl panpan1.1 panPan2
LXN Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 23 51,962,877 - 51,968,447 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 23 51,962,873 - 51,969,172 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 23 51,772,677 - 51,778,236 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 23 52,601,679 - 52,609,457 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 23 52,603,873 - 52,610,212 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 23 52,182,014 - 52,189,772 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 23 52,234,990 - 52,242,749 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 23 52,520,422 - 52,528,212 (-) NCBI UU_Cfam_GSD_1.0
Lxn Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405602 84,460,719 - 84,466,968 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936519 5,266,664 - 5,273,245 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936519 5,266,988 - 5,273,227 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
LXN Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 13 98,435,320 - 98,441,785 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 13 98,435,318 - 98,441,823 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 13 106,728,207 - 106,734,674 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
LXN Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 15 32,170,100 - 32,177,239 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 15 32,171,183 - 32,180,384 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666041 4,734,054 - 4,740,325 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Lxn
.
Predicted Target Of
Count of predictions: 46 Count of miRNA genes: 42 Interacting mature miRNAs: 46 Transcripts: ENSRNOT00000018402 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1578648 Bss11 Bone structure and strength QTL 11 4.7 femur morphology trait (VT:0000559) femoral neck cortical cross-sectional area (CMO:0001702) 2 114837527 211674221 Rat 1298074 Bp164 Blood pressure QTL 164 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 42804607 202447032 Rat 6907363 Bp357 Blood pressure QTL 357 4.1 0.002 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 129540907 174540907 Rat 1354648 Bp239 Blood pressure QTL 239 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 66118463 226797303 Rat 1358360 Sradr2 Stress Responsive Adrenal Weight QTL 2 10.24 adrenal gland mass (VT:0010420) both adrenal glands wet weight (CMO:0000164) 2 129164097 152195315 Rat 1354649 Kidm17 Kidney mass QTL 17 2.9 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 2 81754530 227146641 Rat 10755499 Bp389 Blood pressure QTL 389 2.61 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 18960362 228801039 Rat 1298076 Bp166 Blood pressure QTL 166 0.0009 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 136445150 202447032 Rat 152025245 Scl81 Serum cholesterol level QTL 81 3.49 blood cholesterol amount (VT:0000180) 2 122609194 206936711 Rat 1554319 Bmd2 Bone mineral density QTL 2 13.4 0.0001 lumbar vertebra area (VT:0010570) lumbar vertebra cross-sectional area (CMO:0001689) 2 114837675 212549332 Rat 1581569 Uae32 Urinary albumin excretion QTL 32 0.0001 urine protein amount (VT:0005160) urine albumin excretion rate (CMO:0000757) 2 78665619 219826953 Rat 10043136 Iddm54 Insulin dependent diabetes mellitus QTL 54 3.4 0.0001 blood glucose amount (VT:0000188) age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) 2 143657411 190602963 Rat 61467 Bp14 Blood pressure QTL 14 2.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 43154682 202446871 Rat 70175 BpQTLCluster3 Blood pressure QTL cluster 3 4.128 arterial blood pressure trait (VT:2000000) absolute change in systolic blood pressure (CMO:0000607) 2 135552573 202446871 Rat 1358901 Cm38 Cardiac mass QTL 38 2 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 157142209 Rat 1359030 Bp277 Blood pressure QTL 277 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 114837527 185876470 Rat 1331760 Bp206 Blood pressure QTL 206 3.62454 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 56043031 202447032 Rat 1581502 Esta3 Estrogen-induced thymic atrophy QTL 3 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 2 136916935 189599348 Rat 1358899 Kidm23 Kidney mass QTL 23 3.88 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358908 Bw49 Body weight QTL 49 3.36 body mass (VT:0001259) body weight (CMO:0000012) 2 25413652 157142078 Rat 1582257 Gluco21 Glucose level QTL 21 3.1 0.0035 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 2 118111229 157142209 Rat 1358910 Kidm27 Kidney mass QTL 27 5.77 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358911 Kidm28 Kidney mass QTL 28 5.42 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358904 Cm39 Cardiac mass QTL 39 2.26 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 157142209 Rat 2301966 Bp322 Blood pressure QTL 322 3.58 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 150540301 202447032 Rat 1358887 Bw50 Body weight QTL 50 2.39 body mass (VT:0001259) body weight (CMO:0000012) 2 25413652 157142078 Rat 1298080 Bp163 Blood pressure QTL 163 0.02 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 66118275 202447032 Rat 8662832 Vetf7 Vascular elastic tissue fragility QTL 7 3.5 aorta elastin amount (VT:0003905) aorta wall extracellular elastin dry weight to aorta wall dry weight ratio (CMO:0002002) 2 81689826 221035911 Rat 1298085 Bp165 Blood pressure QTL 165 0.0006 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 42804607 202447032 Rat 1358894 Kidm24 Kidney mass QTL 24 4.03 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1359022 Ppulsi1 Prepulse inhibition QTL 1 3.63 prepulse inhibition trait (VT:0003088) acoustic startle response measurement (CMO:0001519) 2 136916935 213594495 Rat 1641891 Alcrsp17 Alcohol response QTL 17 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 2 149559561 249053267 Rat 724534 Uae6 Urinary albumin excretion QTL 6 10 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 2 78665619 249053267 Rat 61374 Edpm2 Estrogen-dependent pituitary mass QTL 2 4.42 0.86 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 2 76539322 202447032 Rat 631501 Bp101 Blood pressure QTL 101 2.4 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 150341684 202446871 Rat 1331794 Bp202 Blood pressure QTL 202 3.66819 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 141194931 223265385 Rat 71113 Cari2 Carrageenan-induced inflammation QTL 2 2.7 0.009 hypodermis integrity trait (VT:0010550) inflammatory exudate volume (CMO:0001429) 2 141596551 202447032 Rat 1331805 Cm29 Cardiac mass QTL 29 3.50746 heart mass (VT:0007028) heart wet weight (CMO:0000069) 2 141194931 223265385 Rat 634308 Sach6 Saccharin preference QTL 6 4.9 taste sensitivity trait (VT:0001986) saccharin intake volume to total fluid intake volume ratio (CMO:0001601) 2 112456140 212696837 Rat 1598805 Memor8 Memory QTL 8 3 exploratory behavior trait (VT:0010471) average horizontal distance between subject and target during voluntary locomotion in an experimental apparatus (CMO:0002674) 2 150341585 189039377 Rat 1358917 Cm42 Cardiac mass QTL 42 2.82 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 203928301 Rat 724568 Uae13 Urinary albumin excretion QTL 13 4.4 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 2 143157029 210020885 Rat 1358913 Cm41 Cardiac mass QTL 41 2.73 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 203928301 Rat 1300165 Rf9 Renal function QTL 9 3.28 kidney glomerulus integrity trait (VT:0010546) index of glomerular damage (CMO:0001135) 2 133914684 202447032 Rat 61401 Niddm2 Non-insulin dependent diabetes mellitus QTL 2 4.54 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 2 144599348 189599348 Rat 631507 Bp105 Blood pressure QTL 105 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 112456140 212696837 Rat 738007 Anxrr7 Anxiety related response QTL 7 4.4 exploratory behavior trait (VT:0010471) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 2 118189491 163189491 Rat 1641925 Alcrsp2 Alcohol response QTL 2 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 2 149559561 221167075 Rat 1354609 Niddm62 Non-insulin dependent diabetes mellitus QTL 62 4.72 0.000006 insulin secretion trait (VT:0003564) plasma insulin level (CMO:0000342) 2 150540301 202447032 Rat 2293835 Kiddil5 Kidney dilation QTL 5 3.8 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 42804607 157142209 Rat 631520 Bp73 Blood pressure QTL 73 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 147686913 168355276 Rat 1598833 Bp295 Blood pressure QTL 295 3.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 147798556 192798556 Rat 1558653 Prcr1 Prostate cancer resistance QTL 1 5 prostate integrity trait (VT:0010571) area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio (CMO:0000899) 2 72532993 157142209 Rat 1354622 Kidm16 Kidney mass QTL 16 3 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 2 81754530 222436696 Rat 631266 Bp132 Blood pressure QTL 132 0.0005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 46123260 202447032 Rat 2293843 Kiddil6 Kidney dilation QTL 6 3.1 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 42804607 182042367 Rat 1354594 Despr10 Despair related QTL 10 2e-06 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 2 114654253 159654253 Rat 152025206 Hrtrt23 Heart rate QTL 23 5.98 heart pumping trait (VT:2000009) 2 28484589 169504100 Rat 1354605 Rf48 Renal function QTL 48 2.9 blood creatinine amount (VT:0005328) plasma creatinine level (CMO:0000537) 2 74786664 206665859 Rat 6903312 Bw112 Body weight QTL 112 3.2 0.0013 body mass (VT:0001259) body weight (CMO:0000012) 2 143657569 184114274 Rat 152025204 Hrtrt22 Heart rate QTL 22 5.6 heart pumping trait (VT:2000009) 2 28484589 169504100 Rat 1354601 Slep1 Serum leptin concentration QTL 1 5.39 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 2 43171017 184114403 Rat
RH129668
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 151,727,560 - 151,727,742 (+) MAPPER mRatBN7.2 Rnor_6.0 2 164,628,570 - 164,628,751 NCBI Rnor6.0 Rnor_5.0 2 183,977,973 - 183,978,154 UniSTS Rnor5.0 RGSC_v3.4 2 157,310,041 - 157,310,222 UniSTS RGSC3.4 Celera 2 146,097,082 - 146,097,263 UniSTS RH 3.4 Map 2 995.7 UniSTS Cytogenetic Map 2 q31 UniSTS
RH129902
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 151,727,636 - 151,727,835 (+) MAPPER mRatBN7.2 Rnor_6.0 2 164,628,646 - 164,628,844 NCBI Rnor6.0 Rnor_5.0 2 183,978,049 - 183,978,247 UniSTS Rnor5.0 RGSC_v3.4 2 157,310,117 - 157,310,315 UniSTS RGSC3.4 Celera 2 146,097,158 - 146,097,356 UniSTS RH 3.4 Map 2 995.8 UniSTS Cytogenetic Map 2 q31 UniSTS
RH138806
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 151,730,685 - 151,730,845 (+) MAPPER mRatBN7.2 Rnor_6.0 2 164,631,695 - 164,631,854 NCBI Rnor6.0 Rnor_5.0 2 183,981,098 - 183,981,257 UniSTS Rnor5.0 RGSC_v3.4 2 157,313,166 - 157,313,325 UniSTS RGSC3.4 Celera 2 146,100,207 - 146,100,366 UniSTS RH 3.4 Map 2 995.8 UniSTS Cytogenetic Map 2 q31 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000018402 ⟹ ENSRNOP00000018402
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 151,727,102 - 151,733,460 (-) Ensembl Rnor_6.0 Ensembl 2 164,628,566 - 164,634,434 (-) Ensembl
RefSeq Acc Id:
NM_031655 ⟹ NP_113843
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 154,037,604 - 154,043,473 (-) NCBI mRatBN7.2 2 151,727,556 - 151,733,426 (-) NCBI Rnor_6.0 2 164,628,565 - 164,634,434 (-) NCBI Rnor_5.0 2 183,977,968 - 183,983,837 (-) NCBI RGSC_v3.4 2 157,310,036 - 157,315,905 (-) RGD Celera 2 146,097,077 - 146,102,946 (-) RGD
Sequence:
GGAAGAGGGAAGAAGGCGCTGAGGACCGCGCACGCCCAGCCCAGCTGCTGACTTCACCACCTCACCGAGACCCACTCCGCTGGCCAGCACGCTACACTGACAGGATCCTGGCTGCACCCACTGTGATC
hide sequence
RefSeq Acc Id:
NP_113843 ⟸ NM_031655
- UniProtKB:
Q64361 (UniProtKB/Swiss-Prot), A6J5L5 (UniProtKB/TrEMBL)
- Sequence:
MEEIPPTHYAASRAASVAENCINYQQGTPNKVFKVQTVQQASKEDIPGRGHKYHLKFSVEEIIQKQVTVSCTAEVLYPRMGQGSAPEVNFTFEGEIGKNPDEEDNTFYQRLMSMKEPLQAQNIPDNFG
hide sequence
Ensembl Acc Id:
ENSRNOP00000018402 ⟸ ENSRNOT00000018402
RGD ID: 13691366 Promoter ID: EPDNEW_R1891 Type: initiation region Name: Lxn_1 Description: latexin SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 2 164,634,452 - 164,634,512 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2002-06-10
Lxn
latexin
Name updated
70584 APPROVED
Note Type
Note
Reference
gene_expression
enriched in central and peripheral nervous systems, present in lung
633266
gene_protein
223 amino acids
633266
